|
| Status |
Public on Apr 21, 2020 |
| Title |
Lineage-specific chromatin binding of FOXA1 is regulated by LSD1-mediated demethylation |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://doi.org/10.1038/s41588-020-0681-7
|
| |
|
| Citation(s) |
32868907 |
| Submission date |
Apr 21, 2020 |
| Last update date |
Oct 13, 2020 |
| Contact name |
Changmeng Cai |
| E-mail(s) |
changmeng.cai@umb.edu
|
| Organization name |
University of Massachusetts Boston
|
| Street address |
100 William T. Morrissey Blvd.
|
| City |
Boston |
| State/province |
Massachusetts |
| ZIP/Postal code |
02125 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (62)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE114266 |
AR ChIP-seq with DHT induction and GSK treatment |
| GSE114267 |
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks |
| GSE131321 |
H3K4me2 ChIP-seq upon GSK inhibiton |
| GSE148925 |
ATAC-Seq in LNCaP cell line with GSK treatment and VEH control |
| GSE148926 |
ChIP-Seq for FOXA1 in LNCaP cell line with GSK treatment and VEH control |
| GSE148928 |
ChIP-Seq for HOXB13 in LNCaP cell line with GSK treatment and VEH control |
| GSE148982 |
ChIP-Seq for FOXA2 in PC3 cell line with GSK treatment and VEH control |
|
| Relations |
| BioProject |
PRJNA627113 |
Less...
More...